Similar Papers

Paper Title
Journal
Date
Author
Abstract PO-063: Extracellular vesicle miRNAs and autophagic CTCs: Predictive and prognostic biomarkers in radiotherapy treated NSCLC patients
Diego De Miguel Perez ... Jose Antonio Lorente
Clinical Cancer Research | VOL. 27
Diego De Miguel Perez, et. al.Diego De Miguel Perez ... Jose Antonio Lorente
13 Apr 2021
Abstract 4113: Kinase activity based biomarkers: Identification of prognostic and erlotinib response prediction markers in NSCLC patients
Rob Ruijtenbeek ... Rik De Wijn
Cancer Research | VOL. 71
Rob Ruijtenbeek, et. al.Rob Ruijtenbeek ... Rik De Wijn
15 Apr 2011
The association between CD4+ CD25+ regulatory T cells and non-small cell lung carcinoma
Mohamed Abul-Dahab ... Shereen Mohamed Elhoseiny
Comparative Clinical Pathology | VOL. 23
Mohamed Abul-Dahab, et. al.Mohamed Abul-Dahab ... Shereen Mohamed Elhoseiny
30 Oct 2013
Should mediastinoscopy actually be incorporated into the FDG PET strategy for patients with non-small cell lung carcinoma?
Katsumi Hayashi ... Fuzuki Yano
Annals of Nuclear Medicine | VOL. 19
Katsumi Hayashi, et. al.Katsumi Hayashi ... Fuzuki Yano
01 Jul 2005
View more papers

More From: International Journal of Radiation Oncology*Biology*Physics

Paper Title
Journal
Date
Author
Defining the optimal radiation-induced lymphopenia metric to discern its survival impact in esophageal cancer.
Pim J.J Damen ... Peter S.N Van Rossum
International Journal of Radiation Oncology*Biology*Physics | VOL. -
Pim J.J Damen, et. al.Pim J.J Damen ... Peter S.N Van Rossum
01 Jan 2025
Issue Highlights
-
International Journal of Radiation Oncology*Biology*Physics | VOL. -
--
01 Jan 2025
Combined molecular subclass and immune phenotype correlate to atezolizumab plus radiation therapy response in invasive bladder cancer: BPT-ART Phase II study
Yoshiyuki Nagumo ... Hiroyuki Nishiyama
International Journal of Radiation Oncology*Biology*Physics | VOL. -
Yoshiyuki Nagumo, et. al.Yoshiyuki Nagumo ... Hiroyuki Nishiyama
01 Jan 2025
Pelvic regional control with 25Gy in 5 fractions in SBRT for high risk prostate cancer: Pooled prospective outcomes from the SHARP consortium
Vedang Murthy ... Amar U Kishan
International Journal of Radiation Oncology*Biology*Physics | VOL. -
Vedang Murthy, et. al.Vedang Murthy ... Amar U Kishan
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.